{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for icosapent root_names_stdName in Standardized Name (approximate match)
Status:
Possibly Marketed Outside US
Source:
M022
(2024)
Source URL:
First approved in 2011
Source:
M022
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
NADA141322
(2011)
Source URL:
First approved in 2011
Source:
NADA141322
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
21 CFR 352
(2010)
Source URL:
First approved in 2010
Source:
21 CFR 352
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
NDA020062
(2001)
Source URL:
First approved in 1995
Source:
NDA022370
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
First approved in 1993
Source:
21 CFR 352
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
21 CFR 333D
(2015)
Source URL:
First approved in 1989
Source:
ANDA075576
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
NataFort by Mission Pharmacal Company
(2011)
Source URL:
First approved in 1988
Source:
NDA019569
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
ANDA078003
(1989)
Source URL:
First approved in 1988
Source:
21 CFR 333A
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
ANDA074093
(1992)
Source URL:
First approved in 1976
Source:
NDA020353
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
ANDA040904
(2008)
Source URL:
First approved in 1976
Source:
NDA020353
Source URL:
Class:
POLYMER
